Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Role of Biparametric MRI and Image-fusion Targeted Biopsies for Detection of Prostate Cancer

NCT05574647 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05574647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05574647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Role of Biparametric MRI and Image-fusion Targeted Biopsies for Detection of Prostate Cancer
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Recruiting
Start date
November 2, 2022
Completion date
January 31, 2026
Enrollment
3,600 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, neoplasms, prostate cancer, prostatic diseases, prostatic neoplasms